News / 06 Dec 2019
Summit Announces a Proposed Subscription and Placing to Raise approximately $50.0 Million and Notice of General Meeting
News / 06 Nov 2019
Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance Congress
News / 04 Nov 2019
Summit Therapeutics Recognises C. difficile Awareness Month
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer